NCT06306274View on ClinicalTrials.gov

Topical Tacrolimus for Breast Cancer-related Lymphedema

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Lymphedema
Interventions
DRUG

Tacrolimus

Tacrolimus (0,1%) ointment

DRUG

Placebo

Placebo ointment

Trial Locations (3)

4000

Zealand University Hospital, Roskilde

Lillebaelt Hospital, Vejle

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER